.
.it's the first successful medical treatment of a human fetus for the underlying cause of a genetic disorder, experts say.�the kind of review being proposed does not, at least initially, appear to bring anything new or needed to is already a robust system of oversight,� mogulof said in the statement..
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies..
activity.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.